Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 1
2007 2
2008 1
2012 3
2013 6
2014 5
2015 3
2016 1
2017 2
2018 4
2020 3
2021 1
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean neely puri (5 results)?
Potential Telomere-Related Pharmacological Targets.
Berei J, Eckburg A, Miliavski E, Anderson AD, Miller RJ, Dein J, Giuffre AM, Tang D, Deb S, Racherla KS, Patel M, Vela MS, Puri N. Berei J, et al. Among authors: puri n. Curr Top Med Chem. 2020;20(6):458-484. doi: 10.2174/1568026620666200109114339. Curr Top Med Chem. 2020. PMID: 31916516 Review.
Oligonucleotides Targeting Telomeres and Telomerase in Cancer.
Schrank Z, Khan N, Osude C, Singh S, Miller RJ, Merrick C, Mabel A, Kuckovic A, Puri N. Schrank Z, et al. Among authors: puri n. Molecules. 2018 Sep 5;23(9):2267. doi: 10.3390/molecules23092267. Molecules. 2018. PMID: 30189661 Free PMC article. Review.
Resistance to Molecularly Targeted Therapies in Melanoma.
Patel M, Eckburg A, Gantiwala S, Hart Z, Dein J, Lam K, Puri N. Patel M, et al. Among authors: puri n. Cancers (Basel). 2021 Mar 5;13(5):1115. doi: 10.3390/cancers13051115. Cancers (Basel). 2021. PMID: 33807778 Free PMC article. Review.
Treating Cancer by Targeting Telomeres and Telomerase.
Ivancich M, Schrank Z, Wojdyla L, Leviskas B, Kuckovic A, Sanjali A, Puri N. Ivancich M, et al. Among authors: puri n. Antioxidants (Basel). 2017 Feb 19;6(1):15. doi: 10.3390/antiox6010015. Antioxidants (Basel). 2017. PMID: 28218725 Free PMC article. Review.
Current Molecularly Targeting Therapies in NSCLC and Melanoma.
Rajanna S, Rastogi I, Wojdyla L, Furo H, Kulesza A, Lin L, Sheu B, Frakes M, Ivanovich M, Puri N. Rajanna S, et al. Among authors: puri n. Anticancer Agents Med Chem. 2015;15(7):856-68. doi: 10.2174/1871520615666150202100130. Anticancer Agents Med Chem. 2015. PMID: 25642982 Review.
Novel anticancer therapeutics targeting telomerase.
Ruden M, Puri N. Ruden M, et al. Among authors: puri n. Cancer Treat Rev. 2013 Aug;39(5):444-56. doi: 10.1016/j.ctrv.2012.06.007. Epub 2012 Jul 26. Cancer Treat Rev. 2013. PMID: 22841437 Review.
Treatment of Metastatic Melanoma with a Combination of Immunotherapies and Molecularly Targeted Therapies.
Rager T, Eckburg A, Patel M, Qiu R, Gantiwala S, Dovalovsky K, Fan K, Lam K, Roesler C, Rastogi A, Gautam S, Dube N, Morgan B, Nasifuzzaman SM, Ramaswami D, Gnanasekar V, Smith J, Merchant A, Puri N. Rager T, et al. Among authors: puri n. Cancers (Basel). 2022 Aug 3;14(15):3779. doi: 10.3390/cancers14153779. Cancers (Basel). 2022. PMID: 35954441 Free PMC article. Review.
PRMT-1 and p120-Catenin as EMT Mediators in Osimertinib Resistance in NSCLC.
Racherla KS, Dovalovsky K, Patel M, Harper E, Barnard J, Nasifuzzaman SM, Smith M, Sikand R, Drinka E, Puri N. Racherla KS, et al. Among authors: puri n. Cancers (Basel). 2023 Jul 1;15(13):3461. doi: 10.3390/cancers15133461. Cancers (Basel). 2023. PMID: 37444572 Free PMC article.
33 results